ABSTRACT
INTRODUCTION
Transfection of DNA into mammalian cells is a common technique used to study the effects of transient protein expression or to develop stable cell lines. Such experiments allow the structure-function relationships of proteins to be investigated, but it is difficult to monitor the success of these experiments until the endpoint is reached. In the case of transient expression, it is desirable to know the transfection efficiency of a particular experiment; however, reporter molecules like chloramphenicol acetyltransferase or β -galactosidase require the cells to be fixed and incubated with an exogenous substrate, destroying the sample.
Production of stable mammalian cell lines begins with the transfection of the desired cells with a single vector that expresses both the heterologous gene and a selectable marker (e.g., neomycin) or two separate plasmids that express either a heterologous gene or a selectable marker. A few days following transfection, the cells are placed in medium-containing drug (e.g., G418) and selected for 4-8 weeks. Once drugresistant foci have formed, these cells are isolated, expanded out and screened for expression of the desired gene product. Typically, screening of a large number of foci is required to find a population expressing the gene of interest. For many studies, it is also desirable to have a homogeneous population of expressing cells. This can be difficult to determine unless an antibody reactive to the expressed protein is available for indirect immunofluorescence.
To simplify both the determination of transfection efficiency and the selection of mammalian stable cell lines, we have developed expression plasmids containing a hybrid selectable marker that fuses a universal resistance marker, Sh ble , with the versatile reporter molecule, green fluorescent protein (GFP). The Sh ble gene was isolated from Streptoalloteichus hindustanus (Sh) and confers resistance against the antibiotic Zeocin ™, a member of the bleomycin ( ble ) family that is toxic to both prokaryotic and eukaryotic cells (4, 5, 8) . GFP is a protein that fluoresces intracellularly in a wide variety of prokaryotic and eukaryotic organisms without the addition of substrates or cofactors (1) and is easily visualized in tissue culture cells by fluorescence microscopy. The GFP-Zeo R resistance marker was constructed in two different plasmids and allows visual screening of transfected cells by fluorescence and the selection of stable cell lines using Zeocin. This marker is useful to determine the transfection efficiency by fluorescence microscopy without disruption of the cells. Furthermore, this marker can be used to generate stable cell lines by selection against Zeocin, and the success of drug selection can be monitored using fluorescence microscopy. Therefore, selection of mammalian stable cell lines using the hybrid marker is faster than conventional methods, because the success of drug selection can be monitored using fluorescence microscopy.
MATERIALS AND METHODS

Construction of the GFP-Zeo R Fusion
The Zeocin-resistance gene (4) Sh ble is found in plasmids pcDNA3.1/Zeo and pZeoSV2 (Invitrogen, Carlsbad, CA, USA). The cycle-three GFP allele in pAlpha.GFP (3) was used as a template to polymerase chain reaction (PCR)-amplify the gene using the following 5 ′ and 3 ′ primers, 5 ′ -CAAG-GTACCGGTAGAAAAAATGGCTAGCAAAGGAGAAG-3 ′ and 5 ′ -GACATGGGCCCTCATTATTTGTAGAGCTCATC-3 ′ , respectively. The TaqDNA polymerase-generated fragment was then cloned into pCR ® 2.1 using the TA Cloning ® Kit (Invitrogen). The gene was then excised using Kpn I (introduced at the 5 ′ end by PCR) and Sac I (located near the 3 ′ end of GFP), blunted using the Klenow fragment from DNA polymerase and inserted into the unique Msc I site found in the Sh ble sequence of pcDNA3.1/Zeo and pZeoSV2. Transformants were selected on LB/Zeocin plates and examined using low-wave UV light to determine if GFP was present and functional. These plasmids were named pTracer ™-CMV and pTracer ™-SV40, where the cytomegalovirus (CMV) or simian virus 40 (SV40) designation refers to the promoter responsible for heterologous gene expression in mammalian cells ( Figure 1) . A fragment containing the bacterial lacZgene was inserted into both pTracer vectors using Afl II and Apa I sites to construct pTracer-CMV/ lacZand pTracer-SV40/ lacZ .
Transfection and Zeocin Selection of Mammalian Cells
COS-1 and 293 cells were maintained in Dulbecco's modified Eagle medium (DMEM; Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS), and CHO cells were maintained in Ham F-12 media (Life Technologies) supplemented with 10% FBS (JRH Biosciences, Lenexa, KS, USA). Unless noted elsewhere, 60-mm plates containing monolayers of approximately 4 × 10 5 cells were transfected with 20 µ g of DNA using calcium phosphate (Invitrogen) without a glycerol shock. Approximately 2 days post-transfection, cells were selected using medium containing Zeocin (400 µ g/mL).
Fluorescence Microscopy and Photography
Cells were examined after transfection using a Model IX-70 fluorescence inverted microscope (Olympus, Lake Success, NY, USA) equipped with a fluorescein isothiocyanate (FITC) filter. Images were taken with a Model PM20 System (Olympus) using Kodak Ektachrome 400 film.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Immunoblotting
Cell monolayers from transfected 60-mm plates were washed with cold phosphate-buffered saline (PBS), harvested in 1 mL of PBS and pelleted in a microcentrifuge. three freeze-thaw cycles in a dry ice/ethanol and 37°C water bath. After centrifuging for 5 min at 10 000 ×g , the post-nuclear supernatant (20 µ L) was mixed with sample buffer. Each sample was heated to 100°C for 5 min and loaded onto an SDS/4%-20% polyacrylamide gel (Novex, San Diego, CA, USA). After electrophoresis, the proteins were transferred to nitrocellulose and consecutively probed with mouse anti-β -galactosidase serum (Sigma Chemical, St. Louis, MO, USA) diluted to 1:1000 and a goat anti-mouse IgG horseradish peroxidase (HRP) conjugate (Sigma Chemical) diluted to 1:5000. The position of β -galactosidase was detected by enhanced chemiluminescence (ECL ™; Amersham International plc, Little Chalfont, Bucks, England, UK).
RESULTS AND DISCUSSION
Construction of pTracer-CMV and pTracer-SV40
Mammalian expression vectors containing a fluorescent resistance marker were constructed by inserting sequence encoding the cycle-three mutant of GFP (3) into the Sh ble gene of pcDNA3.1/Zeo and pZeoSV2. The ligation reactions to construct each plasmid were plated on LB plates containing Zeocin and the transformants screened for fluorescence using a low-wave UV lamp. Plasmids from fluorescent colonies were screened by restriction digestion, and correct clones were designated pTracer-CMV and pTracer-SV40 (Figure 1) . The cycle-three mutant of GFP was used because it has codons optimized for mammalian expression and 45-fold greater fluorescence than the original GFP allele (3). The Sh ble gene (Zeo R ) is a small (378-bp) resistance marker that can be used for selection in prokaryotes and eukaryotes against the antibiotic Zeocin, a member of the bleomycin family (4, 5, 8) . The small size of the GFP and Zeo R genes (and the resulting fusion) keeps the overall size of the vectors small, allowing for high transformation and transfection efficiencies. Each plasmid has a large multiple cloning site for the insertion of a heterologous gene. pTracer-CMV uses the CMV promoter to drive expression of the heterologous gene and the SV40 late promoter to drive expression of the GFP-Zeo R gene. Conversely, pTracer-SV40 uses the SV40 late promoter to drive expression of the heterologous gene and the CMV promoter to drive expression of the GFP-Zeo R gene. Both plasmids include the EM-7 promoter for expression of the GFP-Zeo R gene in bacteria and the ColE1 origin for replication of the plasmid in bacteria.
Transient Expression Using pTracer
To test expression of a heterologous gene, the gene encoding β -galactosidase, lacZ , was cloned into the pTracer plasmids. pTracer-CMV/ lacZwas transfected into CHO cells and examined for fluorescence and expression of β -galactosidase. Forty-eight hours post-transfection, the CHO cells were examined by light and fluorescence microscopy ( Figure 2, A  and B) . Fluorescence was visible in a number of cells and could be used to estimate the efficiency of transfection, which was approximately 15% in this particular experiment. The cell monolayer was then stained for β -galactosidase activity, and the number of stained cells corresponded well to the number of fluorescent cells ( Figure 2C ). This experiment demonstrated that the GFP fluorescence within transfected cells corresponds to expression of the heterologous gene.
Expression of a heterologous gene and fluorescence of the GFP-Zeo R marker using pTracer-CMV/ lacZand pTracer-SV40/ lacZwas examined in a variety of cell types including 293, CHO and COS. Western blot analysis revealed that each cell type was expressing β -galactosidase 48 h post-transfection ( Figure 3) . The time following transfection required to visualize GFP fluorescence and to detect β -galactosidase expression varied with the pTracer plasmid and cell type used. Typically, cells transfected with pTracer-CMV had visible fluorescence within 48 h, and expression of β -galactosidase was easily detectable after 24 h. Cells transfected with pTracer-SV40 had easily detectable fluorescence within 12 h in COS and CHO cells and 24 h in 293, NIH3T3 and HeLa cells; however, 48 h were typically required to detect expres -sion of β -galactosidase. Higher levels of heterologous expression using pTracer-CMV were also demonstrated by the shorter time required to expose the film. One minute was sufficient for a good signal from pTracer-CMV compared to 30 min for pTracer-SV40. The differences associated with fluorescence and heterologous expression correlate to the promoter driving expression of the GFP-Zeo R gene or the lacZgene. In general, the CMV promoter is stronger and quicker-acting than the SV40 promoter, and this property can be used to determine which plasmid is most useful for a particular study.
For example, if transfected cells are to be sorted by fluorescence-activated cell sorting and quick fluorescence is desirable, the best choice would be pTracer-SV40; however, if high levels of heterologous gene expression are required and the detection of fluorescence can wait 1 or 2 days, then pTracer-CMV would be a good choice.
Selection in Mammalian Cell Lines
The usefulness of GFP-Zeo R for selection of mammalian stable cell lines was tested by transfecting pTracer-SV40/ lacZ into 293 cells using calcium phosphate. Two days post-transfection, the monolayer was examined using light ( Figure 4E ) and fluorescence microscopy ( Figure 4A ). Based on the number of fluorescent cells, the transfection efficiency was estimated to be 14%. At this time, selection of stable cell lines was initiated using medium containing 400 µ g/mL of Zeocin. After 5 days of selection, the cells began to look sick and many began to die (Figure 4F demonstrating that the CMV promoter is stronger in many cell types. Western blot analysis of cell lysates from the selected stable clones also demonstrated that these stable cell lines were expressing β -galactosidase (data not shown). These experiments demonstrate that the fluorescent selectable marker GFP-Zeo R can be used to determine transfection efficiencies of transfected cells and for visual screening of cells during the process of drug selection using the antibiotic Zeocin. The ability to monitor the cell population during drug selection increases the efficiency and decreases the time involved in the production of stable cell lines. Cells transfected with the pTracer plasmids could also be selected or screened using fluorescence-activated cell sorting analysis. Other investigators have demonstrated that expression of GFP can be used to sort cells (2, 6, 7) . Fluorescence-activated cell sorting analysis could potentially be used to sort cell populations with different fluorescence intensities to locate individual cells that have high or low levels of heterologous gene expression. Because plasmids are integrated as a single cassette, it is reasonable to assume that insertion at a transcriptionally active site that results in high-level expression of the fluorescent selectable marker would also have correspondingly high expression of the heterologous gene. Western blot analysis of individual stable cell clones using antiserum against β -galactosidase and GFP has demonstrated this correlation (data not shown). This sort of analysis could be very useful to identify cell lines that overexpress therapeutic protein for purification or to identify genetic loci that have a high transcriptional activity for the purpose of gene expression. Experiments in our lab are underway to determine the utility of the GFP-Zeo R gene for this purpose.
In conclusion, the small size and properties of the Zeocinresistance gene and the GFP reporter molecule allow the production of a marker that is ideally suited for visual screening and selection of transfected mammalian cells. In addition, because the properties of these proteins are universal (i.e., function in many organisms), this marker should be useful in studies of organisms as diverse as bacteria, yeast, fungi, insect cells, other tissue culture cell lines and transgenic animals.
